Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Apr;25(4):413–416. doi: 10.1128/aac.25.4.413

In vitro susceptibilities of human and wild-type isolates of Basidiobolus and Conidiobolus species.

B G Yangco, J I Okafor, D TeStrake
PMCID: PMC185542  PMID: 6329078

Abstract

The in vitro activities of amphotericin B, miconazole, ketoconazole, 5-fluorocytosine, and potassium iodide (KI) were studied on human and wild-type isolates of Basidiobolus and Conidiobolus species. Of the antifungal agents tested, the imidazole derivatives, especially ketoconazole, were the most active against the agents of entomophthoromycosis. Transmission electron microscopy showed severe morphological alteration of Basidiobolus sp. exposed to 0.78 micrograms of ketoconazole per ml. The MIC and minimal fungicidal concentration of ketoconazole was often lowered in the presence of 10% fetal calf serum or antibiotic medium no. 3. Half of the Basidiobolus isolates and all Conidiobolus isolates were inhibited by amphotericin B at 0.39 micrograms/ml. None of the strains tested were inhibited or killed at maximum concentrations of 5-fluorocytosine and KI. The in vitro resistance of these fungi to KI at high concentrations suggests that the reported favorable treatment with KI may not be due to its direct effect on these fungi but rather to other, undefined factors in combination with KI. These data suggest that ketoconazole may be of use in the treatment of entomophthoromycosis, particularly in cases which are not responsive to KI.

Full text

PDF
413

Images in this article

415Image
on p.415

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aerts F., De Brabander M., van den Bossche H., van Cutsem J., Borgers M. The activity of ketoconazole in mixed cultures of fungi and human fibroblasts. Mykosen. 1980 Feb;23(2):53–67. doi: 10.1111/j.1439-0507.1980.tb02581.x. [DOI] [PubMed] [Google Scholar]
  2. Bittencourt A. L., Londero A. T., Araujo M. S., Mendonca N., Bastos J. L. Occurrence of subcutaneous zygomycosis caused by Basidiobolus haptosporus in Brazil. Mycopathologia. 1979 Sep 17;68(2):101–104. doi: 10.1007/BF00441089. [DOI] [PubMed] [Google Scholar]
  3. Brass C., Galgiani J. N., Blaschke T. F., Defelice R., O'Reilly R. A., Stevens D. A. Disposition of ketoconazole, an oral antifungal, in humans. Antimicrob Agents Chemother. 1982 Jan;21(1):151–158. doi: 10.1128/aac.21.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dworzack D. L., Pollock A. S., Hodges G. R., Barnes W. G., Ajello L., Padhye A. Zygomycosis of the maxillary sinus and palate caused by Basidiobolus haptosporus. Arch Intern Med. 1978 Aug;138(8):1274–1276. [PubMed] [Google Scholar]
  5. Eckert H. L., Khoury G. H., Pore R. S., Gilbert E. F., Gaskell J. R. Deep Entomophthora phycomycotic infection reported for the first time in the United States. Chest. 1972 Apr;61(4):392–394. doi: 10.1378/chest.61.4.392. [DOI] [PubMed] [Google Scholar]
  6. Herstoff J. K., Bogaars H., McDonald C. J. Rhinophycomycosis entomophthorae. Arch Dermatol. 1978 Nov;114(11):1674–1678. [PubMed] [Google Scholar]
  7. King D. S. Systematics of fungi causing entomophthoramycosis. Mycologia. 1979 Jul-Aug;11(4):731–745. [PubMed] [Google Scholar]
  8. Martinson F. D. Clinical, epidemiological and therapeutic aspects of entomophthoromycosis. Ann Soc Belg Med Trop. 1972;52(4):329–342. [PubMed] [Google Scholar]
  9. REYNOLDS E. S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol. 1963 Apr;17:208–212. doi: 10.1083/jcb.17.1.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Restrepo A., Greer D. L., Robledo M., Diaz C., Lopez R., Bravo C. Subcutaneous phycomycosis: report of the first case observed in Colombia, South America. Am J Trop Med Hyg. 1967 Jan;16(1):34–39. [PubMed] [Google Scholar]
  11. STRAATSMA B. R., ZIMMERMAN L. E., GASS J. D. Phycomycosis. A clinicopathologic study of fifty-one cases. Lab Invest. 1962 Nov;11:963–985. [PubMed] [Google Scholar]
  12. Stevens D. A., Levine H. B., Deresinski S. C. Miconazole in coccidiodomycosis. II. Therapeutic and pharmacologic studies in man. Am J Med. 1976 Feb;60(2):191–202. doi: 10.1016/0002-9343(76)90428-9. [DOI] [PubMed] [Google Scholar]
  13. Tio T. H., de Vries G. A. Subcutaneous zygomycosis (phycomycosis). S Afr Med J. 1977 Jul 9;52(2):77–78. [PubMed] [Google Scholar]
  14. Wada R. Studies on mode of action of potassium iodide upon sporotrichosis. Mycopathol Mycol Appl. 1968 Mar 22;34(2):97–107. doi: 10.1007/BF02051417. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES